Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 17, Issue 1, January 1992

MONOGRAPHS

AD-5423. Antipsychotic. M.Oka and K. Hino

BF-389. Antiinflammatory. S.J. Lee et al.

BMY 43351. Platelet cAMP phosphodiesterase inhibitor, Platelet aggregation inhibitor. N.A. Meanwell et al.

LY267108. Gastrointestinal prokinetic agent. H.A. Kirst, B. Greenwood and J.S. Gidda

MDL 26,479. Cognition enhancer. J.A. Miller et al.

Ro 15-5458. Antischistosomal. F. Eshete and J.L. Bennett

YM060. 5-HT3 receptor antagonist. M. Ohta and K. Miyata

Correlates in Pharmacostructures

Novel aldose reductase inhibitors: Synthesis and structure-activity studies of (3-benzyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetic acids Y. Itoh, S. Ao, Y. Notsu and M. Hashimoto

REVIEW ARTICLES

Neuropeptide Y and its antagonists M.C. Michel and A. Buschauer

Information Update 1-16

AD-5467
Alinidine
Artemisinin
Batanopride Hydrochloride
Brequinar Sodium
Calcipotriol
Cefcanel Daloxate Hydrochloride
Colforsin
Decitabine
DHAC
Didemnin B
Didox
DM-9384
E-2020
E-3810
Ethacizin
Fazarabine
Fenoldopam Mesylate
Flesinoxan Hydrochloride
Flobufen
Fludarabine Phosphate
FR-74366
GE-410
HGP-30
Loxiglumide
Mespirenone
Milnacipran Hydrochloride
Mildronate
MPC-1304
Naftopidil
NC-1300
Nemonapride
NK-121
Octimibate Sodium
Ondansetron Hydrochloride
Otenzepad
Recainam
Rolipram
Salazodine
Sapropterin Dihydrochloride
SK&F-100330A
SK&F-89976A
SM-10888
Sumatriptan Succinate
Taxol
Trimoprostil
XMMEN-OE5


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy